Journal article
Continuing or ceasing bevacizumab beyond progression in recurrent glioblastoma: an exploratory randomized phase II trial
Elizabeth J Hovey, Kathryn M Field, Mark A Rosenthal, Elizabeth H Barnes, Lawrence Cher, Anna K Nowak, Helen Wheeler, Kate Sawkins, Ann Livingstone, Pramit Phal, Christine Goh, John Simes
Neuro-Oncology Practice | OXFORD UNIV PRESS | Published : 2017
DOI: 10.1093/nop/npw025
Grants
Awarded by NHMRC Program
Funding Acknowledgements
This study was funded by Roche Products, Pty Limited (Australia) with additional support from NHMRC Program Grant 1037786 to the NHMRC Clinical Trials Centre, and Cancer Australia Support for Cancer Clinical Trials Grant and CINSW Cooperative Clinical Trials Grant to COGNO.Dr. Field was funded through the University of Melbourne Stella Mary Langford Scholarship, Watt-Geyer Memorial Research Fund, and the Royal Melbourne Hospital Research Medal